Trump and RFK Jr.'s health industry deals haven't been enforced and are at risk of vanishing

In the midst of his re-election campaign, Republican Rep. Tom Barrett teamed up with Health and Human Services Secretary Robert F. Kennedy Jr. at a large apple orchard in Michigan. They praised President Trump's administration efforts to promote healthier diets, including reducing artificial food dyes. However, many of these high-profile health initiatives depend on voluntary agreements, lacking the enforcement power of traditional federal regulations.

These deals, while popular, often have vague details and limited oversight, making it difficult to track progress. In some cases, the administration has claimed victories that haven't materialized yet. Republicans see these deal-making tactics as a successful strategy, aligning with their anti-regulatory stance and providing quick accomplishments for Trump to tout.

The push to remove certain artificial dyes from food and drugs has been a major headline, but the administration's progress has been inconsistent. For instance, a pledge to remove nine synthetic dyes from foods and medicines by the end of 2025 was only partially met, with only seven of the 27 companies involved actually achieving their goals.

Moreover, no pharmaceutical companies have publicly committed to removing dyes from drugs. The administration's approach of relying on voluntary agreements rather than strict regulations has raised concerns about the sustainability of these initiatives and their impact on public health.